Vasopressin Up-regulates the Expression of Growth-related Immediate-early Genes Via Two Distinct EGF Receptor Transactivation Pathways

Overview

Journal Cell Signal

Date 2008 Jun 24

PMID 18571897

Citations 5

Authors

Lida Q Fuentes

Carlos E Reyes

Jose M Sarmiento

Carolina I Villanueva

Carlos D Figueroa

Javier Navarro

Carlos B Gonzalez

Affiliations

Soon will be listed here.

Abstract

Activation of V(1a) receptor triggers the expression of growth-related immediate-early genes (IEGs), including c-Fos and Egr-1. We found that pre-treatment of rat vascular smooth muscle A-10 cell line with the EGF receptor inhibitor AG1478 or the over-expression of an EGFR dominant negative mutant (HEBCD533) blocked the vasopressin-induced expression of IEGs, suggesting that activation of these early genes mediated by V(1a) receptor is via transactivation of the EGF receptor. Importantly, the inhibition of the metalloproteinases, which catalyzed the shedding of the EGF receptor agonist HB-EGF, selectively blocked the vasopressin-induced expression c-Fos. On the other hand, the inhibition of c-Src selectively blocked the vasopressin-induced expression of Egr-1. Interestingly, in contrast to the expression of c-Fos, the expression of Egr-1 was mediated via the Ras/MEK/MAPK-dependent signalling pathway. Vasopressin-triggered expression of both genes required the release of intracellular calcium, activation of PKC and beta-arrestin 2. These findings demonstrated that vasopressin up-regulated the expression of c-Fos and Erg-1 via transactivation of two distinct EGF receptor-dependent signalling pathways.

Citing Articles

BRET-based assay to monitor EGFR transactivation by the ATR reveals G protein-independent activation and ATR-EGFR complexes.

OBrien S, Johnstone E, Devost D, Conroy J, Reichelt M, Purdue B Biochem Pharmacol. 2018; 158:232-242.

PMID: 30347205 PMC: 8491139. DOI: 10.1016/j.bcp.2018.10.017.

IL-1beta signals through the EGF receptor and activates Egr-1 through MMP-ADAM.

Sanchez-Guerrero E, Chen E, Kockx M, An S, Chong B, Khachigian L PLoS One. 2012; 7(7):e39811.

PMID: 22792188 PMC: 3391205. DOI: 10.1371/journal.pone.0039811.

Constitutive coupling of a naturally occurring human alpha1a-adrenergic receptor genetic variant to EGFR transactivation pathway.

Oganesian A, Yarov-Yarovoy V, Parks W, Schwinn D Proc Natl Acad Sci U S A. 2011; 108(49):19796-801.

PMID: 22089237 PMC: 3241756. DOI: 10.1073/pnas.1116271108.

GPR54 (KISS1R) transactivates EGFR to promote breast cancer cell invasiveness.

Zajac M, Law J, Cvetkovic D, Pampillo M, McColl L, Pape C PLoS One. 2011; 6(6):e21599.

PMID: 21738726 PMC: 3125256. DOI: 10.1371/journal.pone.0021599.

beta-Arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling.

Tilley D, Kim I, Patel P, Violin J, Rockman H J Biol Chem. 2009; 284(30):20375-86.

PMID: 19509284 PMC: 2740462. DOI: 10.1074/jbc.M109.005793.

References

Schafer B, Marg B, Gschwind A, Ullrich A . Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival. J Biol Chem. 2004; 279(46):47929-38. DOI: 10.1074/jbc.M400129200. View

Daaka Y, Pitcher J, Richardson M, Stoffel R, Robishaw J, Lefkowitz R . Receptor and G betagamma isoform-specific interactions with G protein-coupled receptor kinases. Proc Natl Acad Sci U S A. 1997; 94(6):2180-5. PMC: 20061. DOI: 10.1073/pnas.94.6.2180. View

Zhao D, Letterman J, Schreiber B . beta-Migrating very low density lipoprotein (beta VLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor: effect of MAP kinase.... J Biol Chem. 2001; 276(33):30579-88. DOI: 10.1074/jbc.M103761200. View

Luttrell L, Della Rocca G, van Biesen T, Luttrell D, Lefkowitz R . Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J Biol Chem. 1997; 272(7):4637-44. DOI: 10.1074/jbc.272.7.4637. View

Desai B, Rogers M, Chellaiah M . Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol Cancer. 2007; 6:18. PMC: 1828067. DOI: 10.1186/1476-4598-6-18. View

Mukhopadhyay D, Tsiokas L, Zhou X, Foster D, Brugge J, Sukhatme V . Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature. 1995; 375(6532):577-81. DOI: 10.1038/375577a0. View

Al-Sarraj A, Thiel G . Substance P induced biosynthesis of the zinc finger transcription factor Egr-1 in human glioma cells requires activation of the epidermal growth factor receptor and of extracellular signal-regulated protein kinase. Neurosci Lett. 2002; 332(2):111-4. DOI: 10.1016/s0304-3940(02)00939-4. View

Terrillon S, Bouvier M . Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes. EMBO J. 2004; 23(20):3950-61. PMC: 524336. DOI: 10.1038/sj.emboj.7600387. View

Slomiany B, Slomiany A . Src-kinase-dependent epidermal growth factor receptor transactivation in salivary mucin secretion in response to beta-adrenergic G-protein-coupled receptor activation. Inflammopharmacology. 2004; 12(3):233-45. DOI: 10.1163/1568560042342329. View

10.

Altura B, Altura B . Vascular smooth muscle and neurohypophyseal hormones. Fed Proc. 1977; 36(6):1853-60. View

11.

Pierce K, Tohgo A, Ahn S, Field M, Luttrell L, Lefkowitz R . Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J Biol Chem. 2001; 276(25):23155-60. DOI: 10.1074/jbc.M101303200. View

12.

Guerrero J, Santibanez J, Gonzalez A, Martinez J . EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. Exp Cell Res. 2004; 292(1):201-8. DOI: 10.1016/j.yexcr.2003.08.011. View

13.

Caceres M, Guerrero J, Martinez J . Overexpression of RhoA-GTP induces activation of the Epidermal Growth Factor Receptor, dephosphorylation of focal adhesion kinase and increased motility in breast cancer cells. Exp Cell Res. 2005; 309(1):229-38. DOI: 10.1016/j.yexcr.2005.05.020. View

14.

Kreisberg J, Venkatachalam M, Troyer D . Contractile properties of cultured glomerular mesangial cells. Am J Physiol. 1985; 249(4 Pt 2):F457-63. DOI: 10.1152/ajprenal.1985.249.4.F457. View

15.

Segarra G, Medina P, Vila J, Chuan P, Domenech C, Lluch S . Increased contraction to noradrenaline by vasopressin in human renal arteries. J Hypertens. 2002; 20(7):1373-9. DOI: 10.1097/00004872-200207000-00024. View

16.

Alexander L, Ding Y, Alagarsamy S, Cui X, Douglas J . Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor. Kidney Int. 2006; 69(10):1823-32. DOI: 10.1038/sj.ki.5000363. View

17.

Terrillon S, Barberis C, Bouvier M . Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns. Proc Natl Acad Sci U S A. 2004; 101(6):1548-53. PMC: 341772. DOI: 10.1073/pnas.0305322101. View

18.

Gschwind A, Zwick E, Prenzel N, Leserer M, Ullrich A . Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene. 2001; 20(13):1594-600. DOI: 10.1038/sj.onc.1204192. View

19.

Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C . EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 2000; 402(6764):884-8. DOI: 10.1038/47260. View

20.

Gallet C, Blaie S, Levy-Toledano S, Habib A . Epidermal-growth-factor receptor and metalloproteinases mediate thromboxane A2-dependent extracellular-signal-regulated kinase activation. Biochem J. 2003; 371(Pt 3):733-42. PMC: 1223323. DOI: 10.1042/BJ20021030. View